Physician

Pathology

Dr. David M. Loesch, MD

David Loesch works in the field of Pathology. He went to University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care David Loesch is a published doctor as well. He has 24 publications published. The latest was: A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy.

Publications

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic b...
Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer.
Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
Phase I investigation of ametantrone.
Pharmacokinetics of ametantrone acetate (NSC-287513).
A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy.
Eribulin monotherapy versus treatment of physician''s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
A phase II trial of high dose epirubicin in patients with advanced breast carcinoma.
Tandem autotransplantation for the treatment of metastatic breast cancer.
Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer.
Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.
Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu-Negative Metastatic Breast Cancer: A Community-Based Study.
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group.
Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast ca...
Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adju...
Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer.
A phase II trial of weekly paclitaxel, 5-fluorouracil, and leucovorin as first-line treatment for metastatic breast cancer.
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer S...

Schools

University of Mn Med Sch

Conditions Treated

Anemia

Doctors Specialties

Medical Oncology
Oncology
Pathology

Accepted Insurances

Education

University of Texas Health Science Center
West Virginia University
University of Minnesota Medical School

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Roger W. Kwong, MD This Doctor is OpenDoctor Recommended.
	Dr. Alcee J. Jumonville IV, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah R. Hughes, MD This Doctor is OpenDoctor Recommended.
	Dr. James E. Novotny, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel F. Schraith, MD This Doctor is OpenDoctor Recommended.
	Dr. Rodelino R. Virata, MD
	Dr. Richard J. Wittchow, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert S. Witte, MD This Doctor is OpenDoctor Recommended.
	Dr. Gordon G. Zeng, MD This Doctor is OpenDoctor Recommended.
	Dr. Revelino M. Abellera, MD This Doctor is OpenDoctor Recommended.